U. Bergman et al., DRUG UTILIZATION 90-PERCENT - A SIMPLE METHOD FOR ASSESSING THE QUALITY OF DRUG PRESCRIBING, European Journal of Clinical Pharmacology, 54(2), 1998, pp. 113-118
Objectives: To describe a simple method for assessing the quality of d
rug prescribing. Methods: We tested the idea that the number of drugs
accounting for 90% of drug use - drug utilization 90% (DU90%) - may se
rve as an indicator of the quality of drug prescribing. We ranked the
drugs by volume of defined daily doses (DDD) and determined how many d
rugs accounted for the DU90% segment. We also compared this segment wi
th the pharmacotherapeutic guidelines issued by the Regional (local) D
rug Committee to determine the adherence to its recommendations (index
of adherence). The cost per DDD within the DU90% segment and for the
remaining 10% was also calculated. The utilization of drugs based on p
rescriptions purchased during April 1995 was determined for 24 primary
health care (PHC) centres in southwestern Stockholm. Results: The num
ber of different products, defined as all products marketed under a si
ngle brand name within an ATC (anatomic therapeutic chemical) category
, in the DU90% segment varied twofold (81-164) between the 24 PHC cent
res. Differences in the number of GPs per PHC centre accounted for a t
hird of this variation. The compliance with the Drug Committee recomme
ndations varied between 54% and 78%. There was no relationship between
the number of products accounting for the DU90% segment and the adher
ence to local prescription guidelines, i.e. prescribing more products
did not increase the adherence. The costs for the DU90% drugs varied f
rom 2.26 SEK/DDD in one PHC centre to 3.75 in another one, with an ave
rage cost of 2.87 SEK/DDD, while for the remaining 10% it was the doub
le (6:54 SEK/DDD). In all, the DU90% drugs made up 80.8% of the total
cost as compared with 19.2% for the remaining 10%. In the DU90% segmen
t, there was no clear relationship between adherence to the guidelines
and the cost!DDD, i.e. following the evidence-based guidelines appear
ed to provide a higher quality of prescribing rather than cheaper pres
cribing. Conclusions: The DU90% is an inexpensive, flexible, and simpl
e method for assessing the quality of drug prescribing in routine heal
th care. The number of products in the DU90% segment and adherence to
proscription guidelines may serve as general quality indicators. The m
ethod may be adapted to provide comparative data between PHC centres,
hospitals, regions etc. that may be cross-sectional and longitudinal.
Other quality criteria, specific for each class of drugs, should compl
ement these general indicators.